Mousavi S, Nouri S, Sadeghipour A, Atashi A
Ann Hematol. 2025; .
PMID: 39994019
DOI: 10.1007/s00277-025-06237-w.
Paredes-Moscosso S, Nathwani A
Front Oncol. 2025; 14:1429330.
PMID: 39759138
PMC: 11696039.
DOI: 10.3389/fonc.2024.1429330.
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea L
Cells. 2024; 13(23.
PMID: 39682686
PMC: 11640729.
DOI: 10.3390/cells13231937.
Zu Y, Ren Q, Zhang J, Su H, Lu Q, Song Y
Exp Hematol Oncol. 2024; 13(1):104.
PMID: 39462383
PMC: 11515150.
DOI: 10.1186/s40164-024-00577-5.
Ceran F, Basat S, Ersin I, Filinte D, Pilanci O, Bozkurt M
Ulus Travma Acil Cerrahi Derg. 2024; 30(9):626-634.
PMID: 39222497
PMC: 11622727.
DOI: 10.14744/tjtes.2024.77415.
Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma.
Kadono T, Yamamoto S, Kato K
Future Oncol. 2024; 20(28):2097-2107.
PMID: 38861290
PMC: 11497952.
DOI: 10.1080/14796694.2024.2345043.
Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.
Zhang W, Yang P, Yang Y, Liu S, Xu Y, Wu C
J Transl Med. 2024; 22(1):414.
PMID: 38693538
PMC: 11064289.
DOI: 10.1186/s12967-024-05140-8.
Induction of Immunological Antitumor Effects by the Combination of Adenovirus-Mediated Gene Transfer of B7-1 and Anti-Programmed Cell Death-1 Antibody in a Murine Squamous Cell Carcinoma Model.
Hara M, Saburi S, Uehara N, Tsujikawa T, Kubo M, Furukawa T
Cancers (Basel). 2024; 16(7).
PMID: 38611038
PMC: 11010972.
DOI: 10.3390/cancers16071359.
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?.
Riondino S, Rosenfeld R, Formica V, Morelli C, Parisi G, Torino F
Cancers (Basel). 2024; 16(7).
PMID: 38610929
PMC: 11011072.
DOI: 10.3390/cancers16071251.
Challenges and strategies associated with CAR-T cell therapy in blood malignancies.
Liu Z, Lei W, Wang H, Liu X, Fu R
Exp Hematol Oncol. 2024; 13(1):22.
PMID: 38402232
PMC: 10893672.
DOI: 10.1186/s40164-024-00490-x.
Immune checkpoint inhibitors associated cardiovascular immune-related adverse events.
Jo W, Won T, Daoud A, cihakova D
Front Immunol. 2024; 15:1340373.
PMID: 38375475
PMC: 10875074.
DOI: 10.3389/fimmu.2024.1340373.
Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Han X, Zhang H, Sun K, Li J, Wu W, Liu K
Front Immunol. 2024; 14:1302840.
PMID: 38299153
PMC: 10827947.
DOI: 10.3389/fimmu.2023.1302840.
T cell effects and mechanisms in immunotherapy of head and neck tumors.
Xiang Y, Gong M, Deng Y, Wang H, Ye D
Cell Commun Signal. 2023; 21(1):49.
PMID: 36872320
PMC: 9985928.
DOI: 10.1186/s12964-023-01070-y.
Immunotherapeutic and their immunological aspects: Current treatment strategies and agents.
Jain M, Mishra A, Singh M, Shyam H, Kumar S, Shankar P
Natl J Maxillofac Surg. 2023; 13(3):322-329.
PMID: 36683928
PMC: 9851344.
DOI: 10.4103/njms.njms_62_22.
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review.
Koyande N, Srivastava R, Padmakumar A, Rengan A
Vaccines (Basel). 2022; 10(10).
PMID: 36298592
PMC: 9610880.
DOI: 10.3390/vaccines10101727.
Genetic and immune crosstalk between severe burns and blunt trauma: A study of transcriptomic data.
Chen X, Wang K, Li D, Zhao M, Huang B, Su W
Front Genet. 2022; 13:1038222.
PMID: 36246590
PMC: 9561827.
DOI: 10.3389/fgene.2022.1038222.
Mechanism and strategies of immunotherapy resistance in colorectal cancer.
Shan J, Han D, Shen C, Lei Q, Zhang Y
Front Immunol. 2022; 13:1016646.
PMID: 36238278
PMC: 9550896.
DOI: 10.3389/fimmu.2022.1016646.
Co-Stimulatory Receptor Signaling in CAR-T Cells.
Honikel M, Olejniczak S
Biomolecules. 2022; 12(9).
PMID: 36139142
PMC: 9496564.
DOI: 10.3390/biom12091303.
Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer.
Kadono T, Yamamoto S, Kato K
Jpn J Clin Oncol. 2022; 52(10):1089-1096.
PMID: 36047845
PMC: 9538995.
DOI: 10.1093/jjco/hyac138.
Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models.
Zhang P, Li H, Cheng X, Wang W
Biomed Res Int. 2022; 2022:9139823.
PMID: 35872842
PMC: 9303127.
DOI: 10.1155/2022/9139823.
